(S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate,
713, ENA,
713, SDZ ENA,
ENA 713,
ENA 713, SDZ,
ENA-713,
ENA713,
Exelon,
Hydrogen Tartrate, Rivastigmine,
rivastigmine,
Rivastigmine Hydrogen Tartrate,
RivastigmineTartrate,
SDZ ENA 713,
Tartrate, Rivastigmine Hydrogen,
Rivastigmine tartrate,
129101-54-8,
ENA 713,
SDZ-ENA 713,
Rivastigmine bitartrate,
Rivastigmine Hydrogen Tartrate,
Rivastigmine (tartrate),
Rivastigmine hydrogentartrate,
UNII-9IY2357JPE,
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate,
Rivastigmine tartrate (Exelon),
9IY2357JPE,
Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1),
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
N-Ethyl-N-methylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester (2R,3R)-2,3-Dihydroxybutanedioate,
Rivastach,
3-((1S)-1-(Dimethylamino) ethyl)phenyl N-ethyl-N-methylcarbamate,
Exelon MR,
Exelon TDS,
Nimvastid (TN),
(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate,
AK-51757,
Rivastigmine tartrate;,
AC1OCEZZ,
PubChem23268,
Rivastigmine L-Tartrate,
Rivastigmine Tartrate Salt,
rivastigmine-tartrate-exelon,
Rivastigmine tartrate [USP],
MLS006011143,
ENA-713D,
Rivastigmine Hydrogen Tartrate;,
CHEBI:64358,
BH001,
HMS3678F17,
ACT03355,
ONO-2540,
FC0001,
MFCD03700731,
s2087,
AKOS022179413,
AC-3487,
API0005440,
CCG-213410,
CS-0947,
RL01405,
T01R548,
KS-00000H19,
AS-13921,
BC225685,
HY-11017,
LS-49754,
SMR004702920,
AB2000491,
AM20080949,
R0093,
ST24036084,
SW199663-2,
A11719,
D02558,
K-4017,
Q-101313,
3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate,
(S)-N-Ethyl-3-[(1-dimethylamino)ethyl]-N-methylphenylcarbamate hydrogen tartrate,
N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate,
(1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate,
(2R,3R)-2,3-dihydroxybutanedioic acid; [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate,
(S)-Ethylmethylcarbamic Acid 3-[1-(Dimethylamino)ethyl]phenyl Ester [R-(R*,R*)]-2,3-Dihydroxybutanedioate,
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxybutanedioate,
Carbamic acid,ethylmethyl-,3-((1S)-1-(dimethylamino)ethyl)phenyl ester,(2R,3R)-2,3-dihydroxybutanedioate,
Exelon,
rivastigmine,
Prometax,
Exelon (TN),
ENA-713,
SDZ ENA 713,
SDZ-ENA-713,
C14H22N2O2.C4H6O6,
ACN-034451,
CID6918078,
CS-O-02256,
SDZ-212-713,
A8515,
C14-H22-N2-O2.C4-H6-O6,
123441-03-2,
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate,
Rivastigmine tartrate, 98%, acetylcholinesterase and butyrylcholinesterase inhibitor - 1G 1g,